Eric Duraks GLP-1 Exercise Specialist Program reflects his lifelong commitment to bridging fitness and medicine
Aons Chart 1 confirms that while GLP-1 users saw a 7-point improvement in medical spend growth by Year 2 (excluding drug cost), total PMPM including the medication was still 35% higher than the control group ($1,510 vs
It does not tell you what you lost
Product formulation focuses on: 20+ grams of protein per serving Fiber to support satiety Smaller, portion-controlled meals Microwave-ready convenience For large CPG manufacturers, this approach signals a shift from adapting existing products to building entire product lines around GLP-1 consumption habits
Heres a recent review of a way higher quality (journal + publisher + authors + institutions + countries): Its conclusion is clear: The present analyses provide comprehensive evidence that SGLT2 inhibitors improve HF outcomes in patients with HF, T2DM, CKD, and any combination of these diseases, with a consistent but more modest benefit on CV death